NO2930176T3 - - Google Patents

Info

Publication number
NO2930176T3
NO2930176T3 NO13862318A NO13862318A NO2930176T3 NO 2930176 T3 NO2930176 T3 NO 2930176T3 NO 13862318 A NO13862318 A NO 13862318A NO 13862318 A NO13862318 A NO 13862318A NO 2930176 T3 NO2930176 T3 NO 2930176T3
Authority
NO
Norway
Application number
NO13862318A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2930176T3 publication Critical patent/NO2930176T3/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO13862318A 2012-12-10 2013-12-10 NO2930176T3 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012269178 2012-12-10
PCT/JP2013/083022 WO2014092061A1 (ja) 2012-12-10 2013-12-10 ヒダントイン誘導体

Publications (1)

Publication Number Publication Date
NO2930176T3 true NO2930176T3 (hu) 2018-07-07

Family

ID=50934349

Family Applications (1)

Application Number Title Priority Date Filing Date
NO13862318A NO2930176T3 (hu) 2012-12-10 2013-12-10

Country Status (35)

Country Link
US (5) US9428505B2 (hu)
EP (1) EP2930176B1 (hu)
JP (1) JP5951799B2 (hu)
KR (1) KR102168738B1 (hu)
CN (1) CN104854106B (hu)
AU (1) AU2013358167B2 (hu)
BR (1) BR112015012411B1 (hu)
CA (1) CA2892621C (hu)
CL (2) CL2015001391A1 (hu)
CR (1) CR20150272A (hu)
DK (1) DK2930176T3 (hu)
ES (1) ES2663797T3 (hu)
HK (1) HK1209735A1 (hu)
HR (1) HRP20180647T1 (hu)
HU (1) HUE037530T2 (hu)
IL (1) IL238277B (hu)
LT (1) LT2930176T (hu)
MA (1) MA38250B1 (hu)
MX (1) MX2015007309A (hu)
MY (1) MY178583A (hu)
NO (1) NO2930176T3 (hu)
NZ (1) NZ707946A (hu)
PE (1) PE20151295A1 (hu)
PH (1) PH12015501146A1 (hu)
PL (1) PL2930176T3 (hu)
PT (1) PT2930176T (hu)
RS (1) RS57190B1 (hu)
RU (1) RU2678984C2 (hu)
SA (1) SA515360528B1 (hu)
SG (1) SG11201504204XA (hu)
SI (1) SI2930176T1 (hu)
TW (1) TWI615394B (hu)
UA (1) UA115072C2 (hu)
WO (1) WO2014092061A1 (hu)
ZA (1) ZA201503597B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9169254B2 (en) 2009-04-28 2015-10-27 Chugai Seiyaku Kabushiki Kaisha Spiroimidazolone derivative
RS57190B1 (sr) * 2012-12-10 2018-07-31 Chugai Pharmaceutical Co Ltd Derivat hidantoina
KR102266021B1 (ko) * 2014-06-09 2021-06-16 추가이 세이야쿠 가부시키가이샤 히단토인 유도체 함유 의약 조성물
CA3107665A1 (en) 2018-07-30 2020-02-06 Chugai Seiyaku Kabushiki Kaisha Solid dispersion of hydantoin derivative
CN110464002A (zh) * 2019-09-12 2019-11-19 西南石油大学 一种天然冰粉的制备方法及其应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1135470A (ja) 1997-07-23 1999-02-09 Teijin Ltd ビタミンd3誘導体を含有する副甲状腺ホルモン産生促進剤
WO2000035885A1 (en) 1998-12-11 2000-06-22 F. Hoffmann-La Roche Ag Cyclic hydrazine derivatives as tnf-alpha inhibitors
CA2420759A1 (en) 2000-08-30 2003-02-27 Daishiro Miura Parathyroid hormone production inhibitors containing vitamin d3 derivatives
AU2002210813A1 (en) * 2000-10-26 2002-05-06 Pfizer Products Inc. Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
SE0100902D0 (sv) 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
AR038658A1 (es) 2001-06-15 2005-01-26 Novartis Ag Derivados de 4-aril-2(1h) quinazolinona y 4-aril-quinazolina 2-sustituidas, un proceso para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la preparacion de un medicamento
EP1514246A4 (en) * 2002-06-06 2008-04-16 Donnelly Corp COMPASS INTERIOR COURTESY MIRROR SYSTEM
EP1713815A4 (en) 2004-02-11 2009-03-11 Smithkline Beecham Corp PTH AGONISTS
JP2007522215A (ja) 2004-02-11 2007-08-09 スミスクライン・ビーチャム・コーポレイション Pthアゴニスト
EP1799672B1 (en) 2004-10-07 2013-01-02 Merck Sharp & Dohme Corp. Cgrp receptor antagonists
WO2007135417A1 (en) 2006-05-19 2007-11-29 James Black Foundation Benzotriazepinone derivatives
CA2654262A1 (en) 2006-06-20 2007-12-27 Wyeth Kv1.5 potassium channel inhibitors
JP2010529069A (ja) 2007-06-07 2010-08-26 エフ.ホフマン−ラ ロシュ アーゲー Nk3アンタゴニストとしてのプロリンアミド誘導体
PT2444120T (pt) 2007-12-10 2018-01-03 Novartis Ag Análogos da amilorida espirocíclicos como bloqueadores de enac
US7981904B2 (en) 2008-03-20 2011-07-19 Takeda Pharmaceutical Company Limited Acetyl CoA carboxylase inhibitors
US8513193B2 (en) 2008-10-13 2013-08-20 University Of Rochester Protecting and repairing cartilage and musculoskeletal soft tissues
US9169254B2 (en) 2009-04-28 2015-10-27 Chugai Seiyaku Kabushiki Kaisha Spiroimidazolone derivative
RS57190B1 (sr) * 2012-12-10 2018-07-31 Chugai Pharmaceutical Co Ltd Derivat hidantoina
KR102266021B1 (ko) * 2014-06-09 2021-06-16 추가이 세이야쿠 가부시키가이샤 히단토인 유도체 함유 의약 조성물

Also Published As

Publication number Publication date
EP2930176A1 (en) 2015-10-14
CA2892621C (en) 2021-02-16
DK2930176T3 (en) 2018-03-19
IL238277A0 (en) 2015-06-30
PH12015501146B1 (en) 2015-08-10
SI2930176T1 (en) 2018-06-29
CR20150272A (es) 2015-07-09
SG11201504204XA (en) 2015-07-30
IL238277B (en) 2018-01-31
UA115072C2 (uk) 2017-09-11
PH12015501146A1 (en) 2015-08-10
SA515360528B1 (ar) 2018-05-24
TWI615394B (zh) 2018-02-21
EP2930176B1 (en) 2018-02-07
BR112015012411B1 (pt) 2021-10-05
US9428505B2 (en) 2016-08-30
LT2930176T (lt) 2018-04-10
KR102168738B1 (ko) 2020-10-22
MA38250A1 (fr) 2017-02-28
US20180237436A1 (en) 2018-08-23
EP2930176A4 (en) 2016-06-01
CL2017000069A1 (es) 2017-08-25
RU2015127624A (ru) 2017-01-16
MY178583A (en) 2020-10-16
CN104854106B (zh) 2017-07-04
US20150274727A1 (en) 2015-10-01
US20220162208A1 (en) 2022-05-26
PE20151295A1 (es) 2015-10-10
MX2015007309A (es) 2015-09-10
NZ707946A (en) 2019-11-29
US20160326175A1 (en) 2016-11-10
BR112015012411A2 (pt) 2017-07-11
HRP20180647T1 (hr) 2018-06-01
US20210024524A1 (en) 2021-01-28
PL2930176T3 (pl) 2018-07-31
CL2015001391A1 (es) 2015-07-31
AU2013358167A1 (en) 2015-04-09
TW201439092A (zh) 2014-10-16
CA2892621A1 (en) 2014-06-19
KR20150092275A (ko) 2015-08-12
JPWO2014092061A1 (ja) 2017-01-12
CN104854106A (zh) 2015-08-19
RS57190B1 (sr) 2018-07-31
AU2013358167B2 (en) 2017-09-14
ES2663797T3 (es) 2018-04-17
HK1209735A1 (en) 2016-04-08
RU2678984C2 (ru) 2019-02-05
PT2930176T (pt) 2018-04-03
ZA201503597B (en) 2016-09-28
MA38250B1 (fr) 2017-10-31
HUE037530T2 (hu) 2018-09-28
JP5951799B2 (ja) 2016-07-13
WO2014092061A1 (ja) 2014-06-19

Similar Documents

Publication Publication Date Title
BR112014017635A2 (hu)
BR112014017614A2 (hu)
BR112014017592A2 (hu)
AR092201A1 (hu)
BR112014017607A2 (hu)
BR112013027865A2 (hu)
BR112014017634A2 (hu)
BR112014017609A2 (hu)
BR112014023495A2 (hu)
BR112014017588A2 (hu)
BR112014017618A2 (hu)
BR112014013184A8 (hu)
BR112014017621A2 (hu)
BR112014017623A2 (hu)
BR112014017622A2 (hu)
BR112014019869A2 (hu)
BR112014017631A2 (hu)
BR112014017667A2 (hu)
BR112014017600A2 (hu)
BR112014017671A2 (hu)
BR112014017596A2 (hu)
BR112014017591A2 (hu)
BR112014017589A2 (hu)
BR112014017632A2 (hu)
BR112014021534A2 (hu)